Deep Insight is an Israeli venture capital firm that focuses on deep tech opportunities across all development stages. The firm's strategy involves investing in cutting-edge sectors such as semiconductors, bioconvergence, future robotics, advanced materials, photonics, and quantum technologies to support transformative startups.
50% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-b (75% of deals). Average disclosed round size is $59.5M (across 4 rounds with reported amounts).
Portfolio
4
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
4 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Addionics | Series B | $39M | Jul 2024 |
| EExsilio Therapeutics | Series A | $82M | Jun 2024 |
| MMagnus Metal | Series B | $74M | Apr 2024 |
 Bionaut Labs | Series B | $43.2M | Nov 2022 |
Top Co-Investors
Novartis Venture Fund1 shared
Delos Capital1 shared
OrbiMed1 shared
Insight Partners1 shared
Innovation Endeavors1 shared
Invus1 shared
Arc1 shared
Target Global1 shared
Caterpillar1 shared
Awz Ventures1 shared
Lumir1 shared
Discount Capital1 shared
Cresson Management1 shared
Next Gear Ventures1 shared
Essentia Venture Capital1 shared
Khosla Ventures1 shared
OurCrowd1 shared
Sixty Degree Capital1 shared
Dolby Family Ventures1 shared
What If Ventures1 shared
Last updated: 7 April 2026